Related Experiment Video
Updated: Jul 10, 2025
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Emerging frontiers in nanomedicine targeted therapy for prostate cancer
Tayo Alex Adekiya1, Oluwanifemi Owoseni1
1Department of Pharmaceutical Sciences, Howard University, Washington, DC 20059, United States.
Abstract:
Prostate cancer is a prevalent cancer in men, often treated with chemotherapy. However, it tumor cells are clinically grows slowly and is heterogeneous, leading to treatment resistance and recurrence. Nanomedicines, through targeted delivery using nanocarriers, can enhance drug accumulation at the tumor site, sustain drug release, and counteract drug resistance. In addition, combination therapy using nanomedicines can target multiple cancer pathways, improving effectiveness and addressing tumor heterogeneity. The application of nanomedicine in prostate cancer treatment would be an important strategy in controlling tumor dynamic process as well as improve survival. Thus, this review highlights therapeutic nanoparticles as a solution for prostate cancer chemotherapy, exploring targeting strategies and approaches to combat drug resistance.
Insights
Nanomedicine offers a promising approach to overcome chemotherapy resistance in prostate cancer. Therapeutic nanoparticles enhance drug delivery and combat tumor heterogeneity for improved patient survival.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Prostate cancer is a common malignancy in men, frequently managed with chemotherapy.
- Tumor cells exhibit slow growth, heterogeneity, and resistance, leading to treatment failure and recurrence.
- Current chemotherapy faces challenges in efficacy due to tumor characteristics.
Purpose of the Study:
- To review the role of nanomedicine in enhancing prostate cancer chemotherapy.
- To explore nanoparticle-based drug delivery systems for targeted therapy.
- To discuss strategies for overcoming drug resistance and tumor heterogeneity using nanomedicines.
Main Methods:
- Literature review of nanomedicine applications in prostate cancer treatment.
- Analysis of nanoparticle-based drug delivery systems and targeting strategies.
- Examination of combination therapy approaches using nanomedicines.
Main Results:
- Nanomedicines improve drug accumulation at the tumor site via targeted delivery.
- Nanocarriers facilitate sustained drug release and counteract resistance mechanisms.
- Combination nanomedicine therapies address multiple cancer pathways and tumor heterogeneity.
Conclusions:
- Therapeutic nanoparticles represent a significant advancement for prostate cancer chemotherapy.
- Nanomedicine strategies can control tumor dynamics and improve patient survival rates.
- Targeted delivery and combination therapy are key to overcoming treatment resistance.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...